When are they going to make the 4 billion, that's the question? Does your point add up? I will show you biotech that are in phase 3 and have the funds and pipeline is worth alone 2-3 billion and yet day are trading under $2.00, that doesn't mean squat. What the potential is and if the drug ever makes it through the primary end point or even passes through the FDA scrutiny, they will have to constantly fund themselves with dilution.
News 
Market Data 
Discover 
